India will not impose anti-dumping duty on a Chinese chemical used in pharma industry as the finance ministry has not accepted the recommendations of DGTR for imposing the levy. The commerce ministry's investigation arm DGTR had conducted a probe into the alleged dumping of "(4R-Cis)-1-1-Dimethylethyl-6-cyanomethyl-2, 2-dimethyl-1, 3-dioxane-4-acetate" from China, and in August it recommended the imposition of the duty. "The central government, after considering the final findings of the designated authority (DGTR), has decided not to accept the ... recommendations," a memorandum of Department of Revenue said. While Directorate General of Trade Remedies (DGTR) recommends the duty, Department of Revenue takes the final decision to impose it. This chemical is also known as ATS-8, which is a key raw material for manufacturing Atorvastatin active pharmaceutical ingredient. In international trade parlance, dumping happens when a country or a firm exports an item at a price lower than
In international trade parlance, dumping happens when a country or a firm exports an item at a price lower than the price in its domestic market
Countries carry out the anti-dumping probe to determine whether their domestic industries have been hurt because of a surge in below-cost imports
Rashtriya Chemicals and Fertilizers Ltd and Balaji Amines Ltd had filed the application for initiation of the anti-dumping investigations
The domestic industry has suffered material injury due to the dumping of the product